Bank of New York Mellon’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.4M Buy
1,070,183
+259,529
+32% +$6.11M ﹤0.01% 1436
2026
Q1
$12.1M Sell
810,654
-25,493
-3% -$435K ﹤0.01% 1826
2025
Q4
$12.2M Buy
836,147
+29,565
+4% +$516K ﹤0.01% 1819
2025
Q3
$14.5M Sell
806,582
-8,121
-1% -$119K ﹤0.01% 1722
2025
Q2
$13.9M Sell
814,703
-62,106
-7% -$622K ﹤0.01% 1715
2025
Q1
$6.35M Buy
876,809
+42,732
+5% +$486K ﹤0.01% 2088
2024
Q4
$11.7M Buy
834,077
+321,738
+63% +$4.75M ﹤0.01% 1842
2024
Q3
$6.08M Sell
512,339
-161,704
-24% -$1.68M ﹤0.01% 2199
2024
Q2
$6.27M Buy
674,043
+653,838
+3,236% +$3.34M ﹤0.01% 2212
2024
Q1
$71.5K Buy
+20,205
New +$70.1K ﹤0.01% 4061

Other funds holding CORZ

Bank of New York Mellon's CORZ Position: Q2 2026 in Review

Bank of New York Mellon increased its Core Scientific (CORZ) stake by 32% in Q2 2026, buying an estimated $6.11M and bringing the position to 1,070,183 shares worth $27.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Bank of New York Mellon first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. 199 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Bank of New York Mellon held 1,070,183 shares of Core Scientific worth $27.4M as of Q2 2026.
  • Bank of New York Mellon bought 259,529 Core Scientific shares in Q2 2026, an estimated $6.11M.
  • Core Scientific made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1436 holding.
  • Bank of New York Mellon first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • 199 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.